Zhejiang Hisoar Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Haixiang Pharmaceutical Co., Ltd. (abbreviated as Haixiang Pharmaceutical, securities code: 002099) is located in Taizhou, Zhejiang. It is a listed company controlled by Donggang Group and mainly produces characteristic raw materials, preparations, fine chemicals, dyes, and dye intermediates. It is one of the top 100 pharmaceutical industry enterprises with innovative capabilities in China, a key high-tech enterprise under the National Torch Plan, and one of the first batch of integrity demonstration enterprises in Zhejiang Province Zhejiang Province's self operated export excellent production enterprise. The company has jurisdiction over Taizhou Qianjin Chemical Co., Ltd., Zhejiang Haixiang Chuannan Pharmaceutical Co., Ltd., Shanghai Haixiang Pharmaceutical Technology Development Co., Ltd., Zhejiang Haixiang Pharmaceutical Sales Co., Ltd., Taizhou Gangxiang Technology Co., Ltd. and Pujian Co., Ltd. (Germany), and Gangxiang International Holdings (Hong Kong) Co., Ltd. |
| Headquarter | Taizhou |
| Establish Date | 5/7/1998 |
| Listed Code | 002099.SZ |
| Listed Date | 12/26/2006 |
| Chairman | Wang Yangchao. |
| CEO | Xu Guorui. |
| Website | www.hisoar.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
